跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
依非米替片(Ⅰ) - NMPA Drug Approval Details
Approvals
/
NMPA
/
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets(Ⅰ)
Approved
化学药品
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets(Ⅰ)
LAURUS LABS LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Sep 2, 2025
Approval ID
8mkIAWMQCk7
Company
LAURUS LABS LIMITED
Type
化学药品
Approval Details
Approval Id
8mkIAWMQCk7
Approval Number
国药准字HJ20250106
Generic Name
依非米替片(Ⅰ)
Generic Name En
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets(Ⅰ)
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含依非韦伦0.4g,拉米夫定0.3g,富马酸替诺福韦二吡呋酯0.3g。
Reg Date
2025-09-02
Expired Date
2030-09-01
Company Name
LAURUS LABS LIMITED
Production Company Name
LAURUS LABS LIMITED
Company Detail Path
/organization/laurus-labs-limited
Production Company Detail Path
/organization/laurus-labs-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 2, 2025
Approval ID
8mkIAWMQCk7
Type
化学药品
Back to NMPA Approvals